The company has posted a net income of $255.08m, compared to $234.44m for the same period in 2010.
For the first quarter of 2011, Celgene‘s operating income was $287.97m, as compared to $270.25m for the same period last year.
Celgene CEO Bob Hugin said the results for the quarter were outstanding and they reflect the ongoing momentum that Celgene is creating as they leverage their business model and position their company for long-term success.